NOVOCURE LIMITED |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.99 USD | -1.41% |
|
-5.86% | -8.36% |
| Dec. 02 | HC Wainwright Adjusts NovoCure Price Target to $38 From $30, Maintains Buy Rating | MT |
| Dec. 02 | NovoCure's Shares Rise as Pancreatic Cancer Trial Meets Primary Endpoint | MT |
e26291b1cd046.LM-IwxAIj1d14kgSiko8Akx24bG9zUbQBrJlQZowFfM.GoLl80pO3xVGkBFH5x5NcysQrdLfugWoNIQjee4Cb75WlcWcZ3q5NDKaeA~974db7981f05a63b2e72f99be89f2b53